<DOC>
	<DOCNO>NCT03021213</DOCNO>
	<brief_summary>Enhanced external counterpulsation ( EECP ) outpatient coronary artery disease ( CAD ) therapy involve cyclical inflation/deflation cuff wrap around low extremity . However , possible benefit EECP patient heart failure ( HF ) ( New York Heart Association [ NYHA ] class II IV ) cardiomyopathy unclear .</brief_summary>
	<brief_title>Treating Heart Failure With Enhanced External Counterpulsation ( EECP )</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patients heart failure ( NYHA IIIV ) 1. optimal medical therapy 2. cause ischemic nonischemic cardiomyopathy EECPTherapy Treatment Cardio Centrum Berlin Charité University Medicine Berlin Aged 18 100 year Offered patient information write informed consent Participation another interventional trial Acute coronary syndrome &lt; 4 week prior enrollment Operation &lt; 4 week prior enrollment Stroke &lt; 4 week prior enrollment Clinically significant disease hospitalization Aortic valvular heart disease ≥ moderate Aortic aneurysm clinically relevant severe cardiopulmonal disease Resting RR &gt; 160/90mmHg Thrombose , Thrombophlebitis &lt; 8 week prior enrollment Peripheral artery occlusive disease ≥ Stadium II Acute Heart failure Pathological bleeding tendency Arrhythmias , interfere Triggering EECP Other disease , inhibit EECPTreatment ( e.g . Spinal disc herniation ) Accommodation institution due official judicial order Women : pregnancy lactation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>100 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>